On the other hand, high expression of CXCL16 but low ADAM10 expression, which presumably leads to less CXCL16 shedding and accumulation of transmembrane CXCL16, correlated with longer survival in renal cancer patients. Here, CXCL16 is linked to renal carcinoma.